4/25/2012

Corporates have won exemptions for clearing over-the-counter derivatives, but some treasurers are not convinced that they should forgo clearing. Panelists at an industry event said companies should conduct cost-benefit analyses to determine whether central clearing of OTC derivatives is warranted.

Related Summaries